User Overview

Followers and Following

Followers
Following
Trendsmap

History

Total Followers - Last Year
Daily Follower Change - Last Year
Daily Tweets - Last Year

Tweet Stats

Analysed 6,787 tweets, tweets from the last 519 weeks.
Tweets Day of Week (UTC)
Tweets Hour of Day (UTC)
Key:
Tweets
Retweets
Quotes
Replies
Tweets Day and Hour Heatmap (UTC)

Tweets

Last 50 tweets from @SumiSukanya
Sumi Dutta Retweeted ·  
#UzbekistanCoughSyrupCase | Experts point out that laxity on the part of drug regulators has resulted in substandard & adulterated drugs hitting markets in India & other countries with weak regulatory oversight.

@SumiSukanya tells us more 👇
moneycontrol.com/news/trends/wh…

#Uzbekistan
What can the inspection of select drugmaking units hope to achieve?
moneycontrol.com
 
Red-faced over back-to-back allegations of contamination in #coughsyrups supplied outside #India, @CDSCO_INDIA_INF hs started inspection of identified drugmaking units. A knee-jerk reaction or serious effort to fill gaps?
moneycontrol.com/news/trends/wh…

@binoy_prabhakar @WritesRavi
 
A total of 19,227 international pax screened betwn Dec 24- Jan 3 for #COVID-19, 124 found +ve. 11 #SARSCoV2 #Omicron variants so far, mostly #XBB :@MoHFW_INDIA

@Moneycontrol
@binoy_prabhakar
 
Sumi Dutta Retweeted ·  
Possibly sensitive media. Public access unavailable.
 
On Tuesday, #KeralaHighCourt wl pass final order in the #Ribociclib case, a @Novartis drug for HER2 negative #breastcancer patients. Read how the judgement, either way, cd seal the fate fr thousands of patients of this cancer in India.

@binoy_prabhakar @WritesRavi
The Kerala HC is scheduled to pass the final order on a first-of-its-kind petition filed by a breast cancer patient seeking judicial intervention to nudge the govt to help lower the cost of Ribociclib, a critical anti-cancer drug.

Read 👇
moneycontrol.com/news/trends/br…

by @SumiSukanya
 
 
Sumi Dutta Retweeted ·  
A four-member panel under Dr Y K Gupta, which was earlier tasked by the government to investigate the deaths of 70 Gambian kids, is likely to be asked to also probe the latest case involving #MarionBiotech.

Read Here 👇🏻
moneycontrol.com/news/trends/te…

#CoughSyrupDeaths |✍️ @SumiSukanya
 
Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing: @mansukhmandviya
 
Sumi Dutta Retweeted ·  
#Uzbekistan’s Health Ministry has claimed that at least 18 children died after consuming a #coughsyrup manufactured by Noida-based #MarionBiotech. ​

India has initiated a joint inspection of Marion Biotech's Noida facility.

Find out more | @SumiSukanya
Possibly sensitive media. Public access unavailable.
 
Back from Vipassana at Bodh Gaya. Feeling reborn.
10 days without a smartphone and talking, 11 hours a day of meditation and returning with the realisation that we know nothing about ourselves till we "experience" the state of equanimity.
Replying to @alokebajpai
Have been thinking about it. Does it help alleviate the stress related to everyday living later?
 
Sumi Dutta Retweeted ·  
The batches of cough syrup linked to the deaths of 18 kids in Uzbekistan had been exported by Noida-based Marion Biotech to the central Asian country in May 2021

Read Here 👇🏻
moneycontrol.com/news/trends/uz…

#Uzbekistan #CoughSyrupDeaths | ✍️ @SumiSukanya
Uzbekistan cough syrup case: Govt may order category-wise halt of drug production based on probe findings
moneycontrol.com
 
Outside #MarionBiotech, the company which has been blamed by #Uzbekistan for supplying contaminated cough syrup that may have killed 18 kids there.

@binoy_prabhakar @WritesRavi
Possibly sensitive media. Public access unavailable.
 
#MarionBiotech is in the eye of a storm after #Uzbekistan blamed its cough syrups for deaths of 18 kids. #India is now testing all its drugs, mainly syrups, suspensions for possible contamination

@binoy_prabhakar @WritesRavi

moneycontrol.com/news/trends/he…
 
Sumi Dutta Retweeted ·  
In reply to @mansukhmandviya
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory, Chandigarh for testing. (3/3)
 
Sumi Dutta Retweeted ·  
Apology Notice in ⁦@timesofindia⁩ today.
Possibly sensitive media. Public access unavailable.
 
 
Sumi Dutta Retweeted ·  
The Central Drugs Standard Control Organisation has started conducting a joint inspection of identified drug manufacturing units along with state drug control administrations in a risk-based approach.

@SumiSukanya brings more details 👇
moneycontrol.com/news/trends/dr…

#CDSCO #Drugs
 
#Imp: @CDSCO_INDIA_INF along with state drug administrators to inspect identified drug making units across #India at risk of making NSQ/ spurious drugs for #GMP violations.

#MaidenPharma
#CoughSyrupDeaths
 
Sumi Dutta Retweeted ·  
 
Sumi Dutta Retweeted ·  
Here's how much a single dose of Bharat Biotech’s intranasal vaccine #iNCOVACC will cost you in private hospitals👇

moneycontrol.com/news/trends/mc…

@SumiSukanya ✍️ | #COVID19 #COVID19Vaccine
 
 
Looks like Indian media has gone bonkers over BF.7 🤦‍♂️
Why this kolaveri di ? pic.twitter.com/V22jr6PS9g
 
In reply to @mansukhmandviya
@mansukhmandviya holding a #COVID review meeting with state health ministers

#coronavirus #ChinaCovidCases
Possibly sensitive media. Public access unavailable.
 
In reply to @MoHFW_INDIA
@MoHFW_INDIA wants people to take booster doses of #CovidVaccines but has less than 1 crore shots in its kitty and no plans to procure more in the near future for public hospitals. Read our #Exclusive

@binoy_prabhakar @WritesRavi

#coronavirus #ChinaCovidCases
#MCExclusive | Amid the growing #COVID19 scare and increasing public demand for vaccines, the Union government is staring at a stockout, with less than 1 crore shots left in its kitty.

Read on⤵️
moneycontrol.com/news/trends/ex…

By @SumiSukanya | #CovidVaccine #Vaccine #COVID #India
 
Sumi Dutta Retweeted ·  
#BharatBiotech's nasal #COVID19 vaccine is to now be included as a #booster dose in India's immunisation drive against coronavirus.

Can the ones fully vaccinated with Covaxin or Covishield take it? Find out from @SumiSukanya 👇
moneycontrol.com/news/coronavir…

#COVID19Vaccine
Bharat Biotech's nasal Covid vaccine enters India's booster shots list
moneycontrol.com
 
#JustIn: @MoHFW_INDIA to include nasal #COVIDvaccine by @BharatBiotech in Immunization drive against as a #boostershot.

It will now be offered in pvt hospitals to adults earlier fully vaccinated with #Covaxin, #Covishield after the government makes changes in #CoWin
 
Sumi Dutta Retweeted ·  
The situation in #China has triggered global concern even though there is a lack of specific data on disease severity, hospital admissions and intensive-care requirements.

#MCExplains: Why #COVID19 is spiking in China? Know 👇
moneycontrol.com/news/trends/mc…

by @SumiSukanya
Possibly sensitive media. Public access unavailable.
 
#JustIn: @MoHFW_INDIA asks Civil Aviation ministry to ensure that samples of 2% of pax in every flight inbound to #India is tested for #COVID19. If found +ve, these samples to be subjected to genomic sequencing, pax can leave airports after submitting samples

@binoy_prabhakar
 
Sumi Dutta Retweeted ·  
My daughter Dr Trupti Gilada's views on current status of Covid-19

moneycontrol.com/news/trends/mc…
 
Read it to understand why #COVID is back in global spotlight after a long lull.

#COVID19
@binoy_prabhakar @WritesRavi

#China
The situation in #China has triggered global concern even though there is a lack of specific data on disease severity, hospital admissions and intensive-care requirements.

#MCExplains: Why #COVID19 is spiking in China? Know 👇
moneycontrol.com/news/trends/mc…

by @SumiSukanya pic.twitter.com/a97PrK17jm
 
👇This message on #XBB variant circulating on #WhatsApp groups is #Fake, says @Mohfw.

#COVID19
#CovidIsNotOver
#CovidVaccines
Possibly sensitive media. Public access unavailable.
 
 
Masks are back. @mansukhmandviya reviews status in India as #COVID rips through #China

#COVID19 #CovidIsntOver
Possibly sensitive media. Public access unavailable.
 
World is anxious as #China moves from #ZeroCOVIDpolicy to No Covid Policy. What can #India expect? Read what experts say

#chinacovid
@binoy_prabhakar @WritesRavi @GKangInd @AnuragAgrawalMD
As on December 20, the country had recorded 10,072, 004 infections while the number of deaths stood at 31,309 as per official figures.

Read Here 👇🏻
moneycontrol.com/news/trends/ch…

#China #Covid19 | ✍️ @SumiSukanya
 
People tend to see air pollution as a major problem only when the #AQI is in the severe category but that is a complete misnomer, says Dr Arvind Kumar of @medanta. Read this piece to understand why India needs urgent action to tackle #AirPollution.

@binoy_prabhakar @WritesRavi
With strong north-westerly winds improving #AirQuality in #Delhi-NCR marginally over the last few weeks, residents gasping for clean air are heaving a sigh of relief. But top doctors have a warning.

Read on⬇️
moneycontrol.com/news/trends/do…

By @SumiSukanya | #AirQualityIndex #Pollution
 
Sumi Dutta Retweeted ·  
With strong north-westerly winds improving #AirQuality in #Delhi-NCR marginally over the last few weeks, residents gasping for clean air are heaving a sigh of relief. But top doctors have a warning.

Read on⬇️
moneycontrol.com/news/trends/do…

By @SumiSukanya | #AirQualityIndex #Pollution
Don't breathe easy over AQI improvement, air pollution is not just a seasonal problem: Dr Arvind Kumar
moneycontrol.com
 
Over 100 centers in #India sell #StemCellTherapy to gullible parents looking for cure for their autistic kids, exploiting lacuna in reg norms. @NMC_IND now draws line for erring #doctors. Do read this imp report

@binoy_prabhakar @WritesRavi
@drsitu

moneycontrol.com/news/trends/st…
Stem cell therapy not recommended for autistic kids: NMC
moneycontrol.com
 
My son would have turned 27 today. I was told earlier this year he died in a road accident in Mohali. Police did no investigation; closure report was a pack of lies. You can't expect justice from any government @PunjabPoliceInd @DGPPunjabPolice @CMOPb @ArvindKejriwal pic.twitter.com/iamMtyLUo2
Replying to @whoskj2 @PunjabPoliceInd and 3 others
Can't even imagine your pain. I hope there are at least some kind people in @PunjabPoliceInd who will take note and help him get justice.
 
Sumi Dutta Retweeted ·  
My son would have turned 27 today. I was told earlier this year he died in a road accident in Mohali. Police did no investigation; closure report was a pack of lies. You can't expect justice from any government @PunjabPoliceInd @DGPPunjabPolice @CMOPb @ArvindKejriwal
Possibly sensitive media. Public access unavailable.
 
Sumi Dutta Retweeted ·  
HaystackAnalytics, a health-tech startup incubated at the IIT - Bombay, has collaborated with healthcare solution provider LifeCell to offer India’s first genetic test diagnosing drug-resistant #TB.

All you need to know about the test:
moneycontrol.com/news/trends/in…

@SumiSukanya ✍️
India nowhas most comprehensive TB test; can check sensitivity to 18 antibiotics
moneycontrol.com
 
Sumi Dutta Retweeted ·  
India has the highest burden of TB and MDR-TB in the world, disproportionately high even for India’s population.

As per the annual TB report, India had a total of 19,33,381 new and relapsed patients with TB in 2021.

This also included nearly 1,20,000 MDR TB patients
 
Sumi Dutta Retweeted ·  
TB drugs have been given free for years and yet India is home to MDR/XDR TB. Govt answer? Price control for patented drugs.

Two key drugs for drug resistant TB are now essential medicines. But will patients benefit? moneycontrol.com/news/trends/tw…
Two key drugs for drug resistant TB are now essential medicines. But will patients benefit?
moneycontrol.com
 
#Bedaquiline and #Delamanid were two crucial #Tuberculosis drugs among four drugs still under #patent that have been put on the essential medicine list by @MoHFW_INDIA.But will it aid patients' fight in accessing them?Read on

moneycontrol.com/news/trends/tw…

@binoy_prabhakar @WritesRavi
 
A #diabetes drug that is helping many shed kilos quickly has caught the fancy of the rich and commoners alike world over but its high cost in #India is a deterrent for most. Read our report
moneycontrol.com/news/trends/di…

@binoy_prabhakar @WritesRavi
 
Sumi Dutta Retweeted ·  
#TheNews | Mumbai witnesses the highest air pollution in 5 years.
Possibly sensitive media. Public access unavailable.
 
#Paediatricians chart the weight and height of #kids from birth, which is expressed in percentiles based on @WHO standards to assess whether a child is growing well. But soon there will be #India specific standards for this. An interesting report

@binoy_prabhakar @WritesRavi
The Indian government has initiated moves to develop growth standards for children amid concerns that the weight and height references recommended by WHO may not be suitable in the Indian context.

Know more⤵️
moneycontrol.com/news/trends/in…

By @SumiSukanya | #India #Malnutrition #WHO
 
Sumi Dutta Retweeted ·  
Dementia cure remains elusive. The latest trial of a dementia medication yielded mixed results. Although it reduced the amyloid burden in the brain, the clinical benefit to patients was minimal. I am quoted in this article by @SumiSukanya

moneycontrol.com/news/trends/mc…
 
Sumi Dutta Retweeted ·  
#MCExplains | The findings in the #Lecanemab trials have led some international media to call the drug a “momentous breakthrough”.

But is the buzz around this drug in trials for #Alzheimer’s really justified?

Here's what we know 👇
moneycontrol.com/news/trends/mc…

@SumiSukanya ✍️
Possibly sensitive media. Public access unavailable.
 
Sumi Dutta Retweeted ·  
Dementia cure remains elusive. The latest trial results of a dementia medication yielded mixed results. Although it reduced the amyloid burden in the brain, the clinical benefit to patients was minimal. I am quoted in this article by @SumiSukanya

moneycontrol.com/news/trends/mc…
 
Sumi Dutta Retweeted ·  
FII looking for fintech exit, airline deal buzz, founder’s birthday cum reunion bash, poaching rebound for edtech & more in MC Insider

@ashwinmohansays⁩ ⁦@chandrarsrikant⁩ ⁦@Dinesh_Unni⁩ ⁦⁦@rachitaprasad⁩ ⁦@SumiSukanyamoneycontrol.com/news/business/…
 
 
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.